# Enhancing Adaptations to Exercise

> **NCT03350906** · PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 63 (actual)

## Conditions studied

- Inflammation

## Interventions

- **DRUG:** n3-PUFA
- **DRUG:** Placebo
- **PROCEDURE:** Biopsy
- **DIAGNOSTIC_TEST:** Body Composition Scan

## Key facts

- **NCT ID:** NCT03350906
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2023-11-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03350906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03350906, "Enhancing Adaptations to Exercise". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03350906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*